U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07790965) titled 'Study of a Phakic Implantable Collamer Lens (ICL)' on Aug. 22.

Brief Summary: A prospective, open-labeled, single-site study of a phakic implantable collamer lens (ICL) for the correction/reduction of myopia with or without astigmatism.

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL

Condition: Myopia Astigmatism

Intervention: DEVICE: Phakic Implantable Collamer Lens (ICL)

Diffractive Trifocal Phakic ICL

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Staar Surgical Company

Disclaimer: Curated by HT Syndication....